For Q2, Henry Schein (HSIC -2.5%) reported Q2 revenue of $1.68B (-31.2% Y/Y), beating consensus by $300M.
Drop in revenue was mainly due to the impact of pandemic and acquisitions remained immaterial.
Sales breakup: Dental sales -41.2%, Medical sales -11.4%, Technology and Value-Added Services sales -15.9%.
GAAP net loss was $11.4M, or EPS loss of $0.08 Non-GAAP income of $0.6M or EPS of $0 vs Q2 2019 non-GAAP EPS of $0.84.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.